{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:57:22Z","timestamp":1773061042136,"version":"3.50.1"},"reference-count":18,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The aim of this study was to describe the initial 3\u2010year experience in vein\u2010to\u2010vein time for axi\u2010cel therapy and the role of pharmacists in the first recruiting French centers. Retrospective observational data were collected for vein\u2010to\u2010vein time for commercial axi\u2010cel after \u2265 2 lines of systemic therapy between January 2019 and December 2021 in the first 12 authorized French centers. Hospital pharmacists used a circuit database to ensure the prospective traceability at all steps. Totally 501 of the 562 intention\u2010to\u2010treat registrations on the database for cytapheresis (89,1%) led to the infusion of axi\u2010cel. Median vein\u2010to\u2010vein time was shortened by 4\u00a0days. This was mainly due to tightening the interval from apheresis to release. The 36\u2010day median vein\u2010to\u2010vein time achieved after 3\u00a0years' experience should be compared to the 29\u201334\u00a0days reported in Canada, the USA and Israel, where manufacturing sites are geographically closer to hospital centers than they are in France. The top 5 recruiting centers had the shortest vein\u2010to\u2010vein times. This French experience may serve as a model for other European centers, notably as regards deployment of pharmacists to improve the patient pathway with CAR T\u2010cells and other gene and cellular therapies.<\/jats:p>","DOI":"10.1002\/hon.70144","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:50:31Z","timestamp":1761202231000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The French Experience of Pharmacists and CAR T\u2010Cells: A Study of the French Society of Oncology Pharmacy (SFPO)"],"prefix":"10.1002","volume":"43","author":[{"given":"V\u00e9rane","family":"Schwiertz","sequence":"first","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie Groupement Hospitalier Sud Hospices Civils de Lyon  Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"de Jorna","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie H\u00f4pital Saint\u2010Louis Assistance Publique des H\u00f4pitaux de Paris  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeline","family":"Quintard","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie CHU de Montpellier  Montpellier France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie\u2010Antoinette","family":"Lester","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie CHU de Rennes  Rennes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Pinturaud","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie CHRU de Lille  Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Cormier","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie CHU de Nantes  Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"D\u2019Huart","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie CHRU de Nancy  Nancy France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Fougereau","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie Institut Paoli Calmette  Marseille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Carvalho","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie H\u00f4pitaux Universitaires Henri Mondor Assistance Publique des H\u00f4pitaux de Paris  Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Sourisseau","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie CHU de Bordeaux  Bordeaux France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Gueneau","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie CHU de Dijon  Dijon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Wasiak","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie CHU de Clermont\u2010Ferrand  Clermont\u2010Ferrand France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia","family":"Jouvance","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie CHU de Rennes  Rennes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Paul","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie H\u00f4pitaux Universitaires Henri Mondor Assistance Publique des H\u00f4pitaux de Paris  Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gine","family":"Chevrier","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie Centre de lutte contre le cancer Jean Perrin  Clermont\u2010Ferrand France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2388-3518","authenticated-orcid":false,"given":"Bertrand","family":"Pourroy","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie Assistance Publique de Marseille  Marseille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean\u2010Louis","family":"Cazin","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Facult\u00e9 de Pharmacie de Lille UFR 3S Universit\u00e9 de Lille  Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-4231","authenticated-orcid":false,"given":"Florence","family":"Ranchon","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie Groupement Hospitalier Sud Hospices Civils de Lyon  Lyon France"},{"name":"Universit\u00e9 Claude Bernard Lyon I \u2010 EA 3738 CICLY  Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Madelaine\u2010Chambrin","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie H\u00f4pital Saint\u2010Louis Assistance Publique des H\u00f4pitaux de Paris  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Rioufol","sequence":"additional","affiliation":[{"name":"SFPO Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacie Oncologique  Paris France"},{"name":"Pharmacie Groupement Hospitalier Sud Hospices Civils de Lyon  Lyon France"},{"name":"Universit\u00e9 Claude Bernard Lyon I \u2010 EA 3738 CICLY  Lyon France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1708566"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1707447"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2116133"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(22)00662\u20106"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2213614"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2303379"},{"key":"e_1_2_11_8_1","volume-title":"application of the Provisions of Article L. 1151\u20101 of the Public Health Code","year":"2019"},{"key":"e_1_2_11_9_1","volume-title":"Application of the Provisions of Article L. 1151\u20101 of the Public Health Code","year":"2021"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2021.07.002"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0007\u20104551(19)30051\u20107"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2019.08.006"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-94353-0_7"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.003"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409\u2010021\u201001343\u20105"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018\u2010020\u20100074\u2010y"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29120783"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102022\u2010155603"},{"key":"e_1_2_11_19_1","unstructured":"G.Brisou G.Cartron E.Bachyet\u00a0al. Real World Data of Axicabtagene Ciloleucel as Second Line Therapy for Patients With Large B Cell Lymphoma: First Results of a Lysa Study From the French DESCAR\u2010T Registry."}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.70144","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hon.70144","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.70144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:49:09Z","timestamp":1773049749000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.70144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1002\/hon.70144"],"URL":"https:\/\/doi.org\/10.1002\/hon.70144","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"2025-05-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70144"}}